🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Central Centrifugal Cicatricial Alopecia (CCCA)

Deucravacitinib in the Treatment of Cicatricial Alopecias NCT07508488Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Deucravacitinib Tirzepatide for Treatment of CCCA NCT07734870Phase 22 sites📍 Baltimore📍 Columbia Johns Hopkins University · Tests: Tirzepatide A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia NCT04764331NA1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: Revian Red All LED cap Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study NCT04207931Phase 41 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: Topical steroid class I-II, Triamcinolone Acetonide, Doxycyline, Minoxidil Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris NCT07487948Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Delgocitinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy